Info
13F
Schedule 13D

Great Point Partners Llc (Dr. Jeffrey R. Jay, Mr. David Kroin, Ortav Yehudai, Lillian Nordahl) - Significant Ownership

Notable people: Dr. Jeffrey R. Jay, Mr. David Kroin, Ortav Yehudai, Lillian Nordahl
Signature - Title: /s/ Dr. Jeffrey R. Jay, M.D - Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Location: Greenwich, CT
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Great Point Partners Llc.

Significant Ownership of Great Point Partners Llc

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
UNCY	Unicycive Therapeutics, Inc.	Common Stock, par value $0.001 per share	9.99%	$7.23M		11.5M		Great Point Partners, LLC	Dec 31, 2024
PMN	ProMIS Neurosciences Inc.	Common Shares, no par value per share	9.99%	$2.1M		3.33M		Great Point Partners, LLC	Dec 31, 2024
VTGN	Vistagen Therapeutics, Inc.	Common Stock, $0.001 par value per share	6.65%	$4.81M		2.06M	0%	Great Point Partners, LLC	Mar 31, 2025
OTLK	Outlook Therapeutics, Inc.	Common Stock, $0.001 par value per share	6.37%	$3.46M		2.22M	0%	Great Point Partners, LLC	Mar 31, 2025
CNTX	Context Therapeutics Inc.	Common Stock	5.22%	$4.68M		4.68M	0%	Great Point Partners, LLC	Mar 31, 2025
ZURA	Zura Bio Ltd	Class A Ordinary Shares	5.12%	$4.57M		3.17M	0%	Great Point Partners, LLC	May 8, 2025
OPTN	OPTINOSE, INC.	Common Stock, $0.001 par value per share	4.94%	$4.79M	-$3.37M	526K	-41.3%	Great Point Partners, LLC	Mar 31, 2025
NGNE	NEUROGENE INC.	Common Stock, par value $0.000001 per share	2.98%	$6.82M		443K		Great Point Partners, LLC	Dec 31, 2024

Showing 1 to 8 of 8 entries

Schedules 13D/G Reported by Great Point Partners Llc:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.